People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Software / Tech, Other Health Care, Other, Other Technology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nikola Labs Inc. | — | Software / Tech | Series C | $149.5M | $540.6M | 2022 |
| Cognovi Labs, Inc. | — | Software / Tech | Series A | $11.2M | $46.4M | 2021 |
| Atreon Orthopedics LLC | — | Other Health Care | Series A | $5.4M | $48.5M | 2022 |
| Toast Holdings, Inc. | — | Other | Series A | $4.3M | $64.4M | 2017 |
| TegoSens, Inc. | — | Other Health Care | Seed | $1.9M | $35.5M | 2021 |
| Circular Wave Drive Partners Inc. | — | Other Technology | Pre-Seed | $1.8M | $13.5M | 2016 |
| SolitonReach Inc. | — | Other Technology | Pre-Seed | $1.0M | $37.2M | 2016 |
| RenovoDerm, LLC | — | Other Health Care | Pre-Seed | $1.0M | $1.1M | 2023 |
| Ulevo Health, Inc. | — | Healthtech | Pre-Seed | $150K | $1.2M | 2023 |
David Moritz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Moritz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Flavio Lobato | 7 | 17 |
| Rodolfo Bellesi | 6 | 13 |
| Robert Lee | 5 | 12 |
| John D'Orazio | 4 | 8 |
| Erica Waite | 3 | 3 |
| Mario Longhi | 3 | 3 |
| Ross Kayuha | 2 | 7 |
| Ronald Bracken | 2 | 5 |
| William Zell | 2 | 2 |
| James Mainord | 2 | 2 |
| John Young | 1 | 7 |
| Scott Barnes | 1 | 6 |
| William Landman | 1 | 6 |
| Chris Burggraeve | 1 | 4 |
| David Mount | 1 | 3 |
| Mark Davidson | 1 | 3 |
| Brian Graham | 1 | 3 |
| William Ruff | 1 | 2 |
| Michelle Murcia | 1 | 2 |
| Ian Sosso | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.